ZWJ Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.09M | Buy |
8,529
+1,305
| +18% | +$447K | 0.1% | 83 |
|
|
2026
Q1 | $2.54M | Buy |
7,224
+3
| +0% | +$1.07K | 0.09% | 86 |
|
|
2025
Q4 | $2.36M | Hold |
7,221
| – | – | 0.09% | 88 |
|
|
2025
Q3 | $2.04M | Sell |
7,221
-235
| -3% | -$68.2K | 0.07% | 93 |
|
|
2025
Q2 | $2.08M | Sell |
7,456
-19
| -0.3% | -$5.38K | 0.08% | 92 |
|
|
2025
Q1 | $2.33M | Sell |
7,475
-215
| -3% | -$63.5K | 0.09% | 88 |
|
|
2024
Q4 | $2M | Sell |
7,690
-74
| -1% | -$22K | 0.08% | 93 |
|
|
2024
Q3 | $2.5M | Hold |
7,764
| – | – | 0.1% | 82 |
|
|
2024
Q2 | $2.43M | Buy |
7,764
+262
| +3% | +$77K | 0.11% | 79 |
|
|
2024
Q1 | $2.13M | Sell |
7,502
-165
| -2% | -$48.3K | 0.1% | 84 |
|
|
2023
Q4 | $2.21M | Sell |
7,667
-225
| -3% | -$61.3K | 0.11% | 80 |
|
|
2023
Q3 | $2.12M | Buy |
+7,892
| New | +$1.97M | 0.12% | 80 |
|
|
2023
Q2 | – | Sell |
-8,022
| Closed | -$1.94M | – | 195 |
|
|
2023
Q1 | $1.94M | Buy |
8,022
+173
| +2% | +$42.5K | 0.11% | 82 |
|
|
2022
Q4 | $2.06M | Sell |
7,849
-250
| -3% | -$67K | 0.12% | 82 |
|
|
2022
Q3 | $1.83M | Buy |
8,099
+716
| +10% | +$174K | 0.11% | 85 |
|
|
2022
Q2 | $1.8M | Buy |
7,383
+4,572
| +163% | +$1.12M | 0.1% | 83 |
|
|
2022
Q1 | $680K | Hold |
2,811
| – | – | 0.04% | 112 |
|
|
2021
Q4 | $632K | Buy |
+2,811
| New | +$593K | 0.03% | 117 |
|
|
2021
Q3 | – | Sell |
-2,842
| Closed | -$693K | – | 173 |
|
|
2021
Q2 | $693K | Sell |
2,842
-120
| -4% | -$29.5K | 0.04% | 111 |
|
|
2021
Q1 | $737K | Buy |
2,962
+80
| +3% | +$19.1K | 0.05% | 110 |
|
|
2020
Q4 | $663K | Buy |
2,882
+343
| +14% | +$79.1K | 0.05% | 109 |
|
|
2020
Q3 | $645K | Sell |
2,539
-315
| -11% | -$78K | 0.05% | 98 |
|
|
2020
Q2 | $673K | Sell |
2,854
-123
| -4% | -$28.1K | 0.06% | 98 |
|
|
2020
Q1 | $604K | Hold |
2,977
| – | – | 0.05% | 128 |
|
|
2019
Q4 | $718K | Buy |
2,977
+123
| +4% | +$27.1K | 0.05% | 129 |
|
|
2019
Q3 | $552K | Hold |
2,854
| – | – | 0.04% | 106 |
|
|
2019
Q2 | $526K | Sell |
2,854
-175
| -6% | -$31.3K | 0.04% | 107 |
|
|
2019
Q1 | $575K | Sell |
3,029
-304
| -9% | -$58.1K | 0.05% | 105 |
|
|
2018
Q4 | $649K | Buy |
3,333
+564
| +20% | +$110K | 0.06% | 96 |
|
|
2018
Q3 | $574K | Sell |
2,769
-100
| -3% | -$19.7K | 0.05% | 106 |
|
|
2018
Q2 | $530K | Hold |
2,869
| – | – | 0.05% | 106 |
|
|
2018
Q1 | $489K | Sell |
2,869
-4,328
| -60% | -$794K | 0.04% | 106 |
|
|
2017
Q4 | $1.25M | Buy |
7,197
+595
| +9% | +$105K | 0.1% | 99 |
|
|
2017
Q3 | $1.23M | Sell |
6,602
-51
| -0.8% | -$9.04K | 0.1% | 96 |
|
|
2017
Q2 | $1.15M | Sell |
6,653
-600
| -8% | -$97.6K | 0.09% | 105 |
|
|
2017
Q1 | $1.19M | Buy |
7,253
+4,710
| +185% | +$783K | 0.1% | 104 |
|
|
2016
Q4 | $372K | Buy |
2,543
+1,100
| +76% | +$166K | 0.04% | 120 |
|
|
2016
Q3 | $241K | Buy |
1,443
+90
| +7% | +$15.2K | 0.02% | 135 |
|
|
2016
Q2 | $206K | Sell |
1,353
-30
| -2% | -$4.66K | 0.02% | 147 |
|
|
2016
Q1 | $207K | Sell |
1,383
-115
| -8% | -$17.1K | 0.02% | 148 |
|
|
2015
Q4 | $243K | Buy |
1,498
+21
| +1% | +$3.3K | 0.03% | 134 |
|
|
2015
Q3 | $204K | Hold |
1,477
| – | – | 0.02% | 132 |
|
|
2015
Q2 | $227K | Buy |
+1,477
| New | +$237K | 0.02% | 134 |
|
Other funds holding AMGN
FFM
SP
BCWM
SMDAM
ZWJ Investment Counsel's AMGN Position: Q2 2026 in Review
ZWJ Investment Counsel increased its Amgen (AMGN) stake by 18% in Q2 2026, buying an estimated $447K and bringing the position to 8,529 shares worth $3.09M. The position accounts for 0.1% of the portfolio, ranked #83.
ZWJ Investment Counsel first reported a position in AMGN in Q2 2015 and has held it in 43 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- ZWJ Investment Counsel held 8,529 shares of Amgen worth $3.09M as of Q2 2026.
- ZWJ Investment Counsel bought 1,305 Amgen shares in Q2 2026, an estimated $447K.
- Amgen made up 0.1% of ZWJ Investment Counsel's portfolio in Q2 2026, its #83 holding.
- ZWJ Investment Counsel first reported a position in Amgen in Q2 2015 and has held it in 43 quarters since.
- 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on ZWJ Investment Counsel's 13F filing for Q2 2026, filed 16 Jul 2026.